ATLANTIC TECHNOLOGY VENTURES INC
S-3, EX-5.5, 2000-07-06
PHARMACEUTICAL PREPARATIONS
Previous: ATLANTIC TECHNOLOGY VENTURES INC, S-3, 2000-07-06
Next: ATLANTIC TECHNOLOGY VENTURES INC, S-3, EX-23.1, 2000-07-06





                                                                     Exhibit 5.1

                       KRAMER LEVIN NAFTALIS & FRANKEL LLP
                                919 THIRD AVENUE
                           NEW YORK, N.Y. 10022 - 3852


 TEL (212) 715-7787                                            47, Avenue Hoche
 FAX (212) 715-8047                                              75008 Paris
                                                                   France

                                                    July 6, 2000

Atlantic Technology Ventures, Inc.
150 Broadway
Suite 1009
New York, NY 10038

                           Registration Statement on Form S-3
                           ----------------------------------

Ladies and Gentlemen:

                  We have acted as counsel to Atlantic Technology Ventures,
Inc., a Delaware corporation (the "Company"), in connection with the preparation
and filing of a Registration Statement on Form S-3 (the "Registration
Statement") with the Securities and Exchange Commission (the "Commission"), with
respect to the registration for resale under the Securities Act of 1933, as
amended (the "Act"), of 200,000 shares of the Company's common stock, par value
$.001 per share, issued by the Company to the selling shareholders named in the
Registration Statement (the "Shares") and 200,000 shares of the Company's common
stock issuable by the Company to the selling shareholders named in the
Registration Statement upon exercise of certain warrants (the "Warrant Shares").

                  In connection with the registration of the Shares and the
Warrant Shares, we have reviewed such documents and records as we have deemed
necessary to enable us to express an opinion on the matters covered hereby. In
rendering this opinion, we have (a) assumed (i) the genuineness of all
signatures on all documents examined by us, (ii) the authenticity of all
documents submitted to us as originals, and (iii) the conformity to original
documents of all documents submitted to us as photostatic or conformed copies
and the authenticity of the originals of such copies; and (b) relied (i) on
certificates of public officials and (ii) as to matters of fact, statements and
certificates of officers and representatives of the Company.

                  Based upon the foregoing, we are of the opinion that the
Shares have been validly issued, fully paid and non-assessable, and that the
Warrant Shares will, upon issuance, be validly issued, fully paid and
non-assessable.

                  We hereby consent to the use of this opinion as an exhibit to
the Registration Statement. In giving the foregoing consent, we do not thereby
admit that we are in the category of persons whose consent is required under
Section 7 of the Act or the rules and regulations of the Commission thereunder.

                                         Very truly yours,


                                         /s/ Kramer Levin Naftalis & Frankel LLP




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission